These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3938207)

  • 1. Antidopaminergic effects of bisbenzyl and benzyl tetrahydroisoquinoline alkaloids.
    Watanabe H; Uramoto H; Maeda-Hagiwara M; Kikuchi T
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):53-60. PubMed ID: 3938207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A; Flauto C; Parati E; Vescovi A; Rusconi L; Parenti M
    J Neural Transm Suppl; 1986; 22():33-45. PubMed ID: 2946813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
    Martin GE; Williams M; Haubrich DR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):298-304. PubMed ID: 6813451
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of chronic bromocriptine treatment on behaviour and dopamine receptor binding in the rat striatum.
    Traub M; Wagner HR; Hassan M; Jackson-Lewis V; Fahn S
    Eur J Pharmacol; 1985 Nov; 118(1-2):147-54. PubMed ID: 3936723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO].
    Martin GE; Williams M; Pettibone DJ; Yarbrough GG; Clineschmidt BV; Jones JH
    J Pharmacol Exp Ther; 1984 Sep; 230(3):569-76. PubMed ID: 6433000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model.
    Hruska RE; Silbergeld EK
    Science; 1980 Jun; 208(4451):1466-8. PubMed ID: 7189902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A; Ceresoli G; Mandelli V; Parenti M
    J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interaction of simple tetrahydroisoquinolines with opiate and high-affinity dopamine (D3) receptors in the rat corpus striatum].
    Patsenko AA; Grinevich VP; Ostrovskiĭ IuM
    Farmakol Toksikol; 1987; 50(4):33-5. PubMed ID: 2822473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor stimulating effects of chanoclavine analogues, tricyclic ergot alkaloids, in the brain.
    Watanabe H; Somei M; Sekihara S; Nakagawa K; Yamada F
    Jpn J Pharmacol; 1987 Dec; 45(4):501-6. PubMed ID: 3127619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the calcium channel blockers on rotation induced by apomorphine and amphetamine in rats lesioned with 6-hydroxydopamine].
    Tabernero C; Pardo B; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(2):49-53. PubMed ID: 1907126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives.
    El Aouad N; Berenguer I; Romero V; Marín P; Serrano A; Andujar S; Suvire F; Bermejo A; Ivorra MD; Enriz RD; Cabedo N; Cortes D
    Eur J Med Chem; 2009 Nov; 44(11):4616-21. PubMed ID: 19628309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: Comparison between systemic and intrastriatal injections.
    Herrera-Marschitz M; Forster C; Ungerstedt U
    Acta Physiol Scand; 1985 Nov; 125(3):519-27. PubMed ID: 3936338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
    Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
    Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estradiol on intact and denervated striatal dopamine receptors and on dopamine levels: a biochemical and behavioral study.
    Di Paolo T; Bédard PJ; Dupont A; Poyet P; Labrie F
    Can J Physiol Pharmacol; 1982 Mar; 60(3):350-7. PubMed ID: 7200388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of fluphenazine-N-mustard on dopamine binding sites and on behavior induced by apomorphine in supersensitive mice.
    Thermos K; Winkler JD; Weiss B
    Neuropharmacology; 1987 Oct; 26(10):1473-80. PubMed ID: 3120028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High- and low-affinity states of striatal D2 receptors are not affected by 6-hydroxydopamine or chronic haloperidol treatment.
    MacKenzie RG; Zigmond MJ
    J Neurochem; 1984 Nov; 43(5):1310-8. PubMed ID: 6208330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.